Pneumoconiosis surgery: Difference between revisions
Jump to navigation
Jump to search
Line 8: | Line 8: | ||
==Indications== | ==Indications== | ||
*Surgery is not the first-line treatment option for patients with pneumoconiosis. Surgery is usually reserved for patients with either: <ref name="pmid32310362">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume= | issue= | pages= | pmid=32310362 | doi= | pmc= | url= }} </ref> <ref name="pmid29773095">{{cite journal| author=Li J, Yao W, Hou JY, Zhang L, Bao L, Chen HT | display-authors=etal| title=The Role of Fibrocyte in the Pathogenesis of Silicosis. | journal=Biomed Environ Sci | year= 2018 | volume= 31 | issue= 4 | pages= 311-316 | pmid=29773095 | doi=10.3967/bes2018.040 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29773095 }} </ref> | *Surgery is not the first-line treatment option for patients with pneumoconiosis. Surgery is usually reserved for patients with either: <ref name="pmid32310362">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume= | issue= | pages= | pmid=32310362 | doi= | pmc= | url= }} </ref> <ref name="pmid29773095">{{cite journal| author=Li J, Yao W, Hou JY, Zhang L, Bao L, Chen HT | display-authors=etal| title=The Role of Fibrocyte in the Pathogenesis of Silicosis. | journal=Biomed Environ Sci | year= 2018 | volume= 31 | issue= 4 | pages= 311-316 | pmid=29773095 | doi=10.3967/bes2018.040 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29773095 }} </ref> <ref name="pmid22071439">{{cite journal| author=Singer JP, Chen H, Phelan T, Kukreja J, Golden JA, Blanc PD| title=Survival following lung transplantation for silicosis and other occupational lung diseases. | journal=Occup Med (Lond) | year= 2012 | volume= 62 | issue= 2 | pages= 134-7 | pmid=22071439 | doi=10.1093/occmed/kqr171 | pmc=3283165 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22071439 }} </ref> | ||
**Advanced disease | |||
**Pulmonary hypertension | **Pulmonary hypertension | ||
**Respiratory failure | **Respiratory failure |
Revision as of 20:04, 28 April 2021
Pneumoconiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pneumoconiosis surgery On the Web |
American Roentgen Ray Society Images of Pneumoconiosis surgery |
Risk calculators and risk factors for Pneumoconiosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
Surgical intervention is not recommended for the management of pneumoconiosis. Severe cases of the condition can be treated with a lung transplant. [1]
Indications
- Surgery is not the first-line treatment option for patients with pneumoconiosis. Surgery is usually reserved for patients with either: [2] [3] [4]
- Advanced disease
- Pulmonary hypertension
- Respiratory failure
- Cor pulmonale
Surgery
References
- ↑ Cullinan P, Reid P (2013). "Pneumoconiosis". Prim Care Respir J. 22 (2): 249–52. doi:10.4104/pcrj.2013.00055. PMC 6442808. PMID 23708110.
- ↑ "StatPearls". 2021. PMID 32310362 Check
|pmid=
value (help). - ↑ Li J, Yao W, Hou JY, Zhang L, Bao L, Chen HT; et al. (2018). "The Role of Fibrocyte in the Pathogenesis of Silicosis". Biomed Environ Sci. 31 (4): 311–316. doi:10.3967/bes2018.040. PMID 29773095.
- ↑ Singer JP, Chen H, Phelan T, Kukreja J, Golden JA, Blanc PD (2012). "Survival following lung transplantation for silicosis and other occupational lung diseases". Occup Med (Lond). 62 (2): 134–7. doi:10.1093/occmed/kqr171. PMC 3283165. PMID 22071439.